Financial reports
10-K
2023 FY
Annual report
11 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
21 Mar 22
Current reports
8-K
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
11 Mar 24
8-K
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
22 Jan 24
8-K
Results of Operations and Financial Condition
9 Jan 24
8-K
Other Events
11 Dec 23
8-K
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
6 Nov 23
8-K
Other Events
23 Oct 23
8-K
ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
10 Aug 23
8-K
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
27 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
8 May 23
Registration and prospectus
S-3ASR
Automatic shelf registration
11 Mar 24
D
$125.00 mm in equity, sold $125.00 mm, 10 investors
30 Jan 24
S-3
Shelf registration
26 Jan 24
S-3
Shelf registration
15 Dec 23
D
Exempt offering of security
5 Jul 23
S-8
Registration of securities for employees
16 Mar 23
424B5
Prospectus supplement for primary offering
21 Dec 22
SC TO-I/A
Issuer tender offer statement (amended)
21 Jul 22
SC TO-I
Issuer tender offer statement
21 Jun 22
S-8
Registration of securities for employees
22 Mar 22
Other
EFFECT
Notice of effectiveness
5 Feb 24
CORRESP
Correspondence with SEC
31 Jan 24
UPLOAD
Letter from SEC
31 Jan 24
EFFECT
Notice of effectiveness
29 Dec 23
CORRESP
Correspondence with SEC
26 Dec 23
UPLOAD
Letter from SEC
22 Dec 23
EFFECT
Notice of effectiveness
28 Apr 22
EFFECT
Notice of effectiveness
13 Nov 20
CORRESP
Correspondence with SEC
10 Nov 20
CORRESP
Correspondence with SEC
10 Nov 20
Ownership
SC 13G/A
FMR LLC
11 Mar 24
4
Jacob Chacko
8 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
ALKEON CAPITAL MANAGEMENT LLC
13 Feb 24
SC 13G/A
Prosight Management, LP
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Jacob Chacko
8 Feb 24
SC 13G/A
BlackRock Inc.
7 Feb 24
SC 13G/A
MILLENNIUM MANAGEMENT LLC
6 Feb 24